- Market Capitalization, $K 1,096,632
- Shares Outstanding, K 25,509
- Annual Sales, $ 10,390 K
- Annual Income, $ -51,010 K
- 60-Month Beta -0.34
- Price/Sales 106.80
- Price/Cash Flow N/A
- Price/Book 6.78
|Period||Period Low||Period High||Performance|
| || |
+9.37 (+28.19%)since 08/27/21
| || |
+11.57 (+37.27%)since 06/25/21
| || |
+23.60 (+124.15%)since 09/25/20
Ionis (IONS) incurs wider-than-expected Q2 loss. The company maintains its sales guidance for 2021 but expects to incur more losses.
Following a positive recovery from COVID-impacts, Alkermes (ALKS) beat both earnings and sales estimates in second-quarter 2021. The company also raised its guidance for 2021.
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. The company also raises its guidance for 2021. Resultantly, the stock rises.
The Barchart Chart of the Day belongs to the biomedical company Bicycle Therapeutics (NASDAQ: BCYC ). Readers are always asking me how to find stocks that are just beginning to trend before everyone...
Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks...
Athenex (ATNX) announces approval for its skin treatment drug, Klisyri, in Europe. The company's partner Almirall is set to handle the launch of the drug in the region.
Albireo's (ALBO) Bylvay becomes the first and only drug to treat progressive familial intrahepatic cholestasis, following its approval in Europe.
Ionis (IONS) signs a deal with Bicycle Therapeutics to incorporate the latter's optimized Bicycle peptides into its LICA delivery platform.
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that it has entered into an exclusive licensing agreement with Bicycle Therapeutics plc (NASDAQ: BCYC) to increase the delivery...
Bicycle Therapeutics PLC Sponsored ADR (BCYC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks...
|3rd Resistance Point||46.38|
|2nd Resistance Point||45.50|
|1st Resistance Point||44.06|
|1st Support Level||41.74|
|2nd Support Level||40.86|
|3rd Support Level||39.42|